Media

Filter by Category

All Blog Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

September 14, 2021

Inter-rater reliability of the neonatal adverse event severity scale using real-world Neonatal clinical trial data

RARE-X and Critical Path Institute align on their mission and commitment for data sharing to improve rare disease research TUCSON,

C-Path, NORD and FDA have spent two years building the platform set to launchSept. 14 at the 2021 RDCA-DAP Workshop. TUCSON, Ariz.

October 19, 2021-October 20, 2021

C-Path’s International Neonatal Consortium held its two-day annual scientific meeting in a virtual format, October 19-20, 2

August 17, 2021

C-Path’s Neuroscience Program hosted its first webinar on August 17, 2021. This webinar brought together more than 330 members,

C-Path is proud to welcome Medable, Inc as the newest member of its Electronic Patient-Reported Outcome Consortium. Compr

TUCSON, Ariz., August 18, 2021— Critical Path Institute (C-Path) is pleased to announce that it has selected Kevin Perkins as it

As we observe National Nonprofit Day and recognize the invaluable effort nonprofits put towards making an impact in our communitie

August 7, 2021

September 14, 2021

The Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP®) is an FDA-funded initiative with the goal of accelerat